https://clinicaltrials.gov/ct2/show/NCT02630459?type=Intr&cond=Migraine&lupd_s=02%2F27%2F2019&lupd_d=14
Condition : Migraine
Interventions : Drug: Placebo; Drug: Erenumab
Sponsor : Amgen
Active, not recruiting
A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention
NCT02630459
Tue, 15 Dec 2015 12:00:00 EST
Last Update Posted: 03/13/19 10:21AM